Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Dual approach is safe, effective during phacoemulsification
New York-A dual approach to viscoelastic use during phacoemulsification combining 2% hydroxypropyl methylcellulose (Ocucoat, Bausch & Lomb Surgical) and sodium hyaluronate (Amvisc Plus, Bausch & Lomb Surgical) affords surgeons the opportunity to benefit from the positive features of each and allows surgery to be performed very safely and efficiently, said Robert Ditkoff, MD.
Related Videos
Related Content
